Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEMETIS, INCAMTX · Entity 6595 | Executive Vice President, CFO | March 19, 2026 | March 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEMETIS, INC
Report date March 19, 2026 · Filed March 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.64 · Expires 2036-03-19 | Direct | 1,305,701 |
Reported balance
After 2026-03-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-19 · Grant · Acquired 200,000 · Balance 1,305,701 F1: 1/12th of the option shares vest every three months from the grant date |
Filing footnotes · ownership attribution and instrument terms
F1: 1/12th of the option shares vest every three months from the grant date
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2021 Filed Feb 17, 2021 00:27 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $7.80 Strike: $2.54 | $78,000.00 |
DisclosureSEC source: 0001593968-21-000498 · primary_01.xml · derivative · entry 2 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock and Series B Preferred · 10,000 shares Expires 2026-05-21 F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan. F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
| February 16, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $7.80 | $78,000.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 14 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 00:27 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $7.24 Strike: $2.54 | $72,400.00 |
DisclosureSEC source: 0001593968-21-000498 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common stock and Series B Preferred · 10,000 shares Expires 2026-05-21 F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan. F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
| February 12, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $7.24 | $72,400.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 13 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| February 11, 2021 Filed Feb 12, 2021 00:53 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $7.71 Strike: $2.54 | $77,100.00 |
DisclosureSEC source: 0001593968-21-000408 · primary_01.xml · derivative · entry 2 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common stock and Series B Preferred · 10,000 shares Expires 2026-05-21 F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan. F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
| February 11, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $7.71 | $77,100.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 12 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 00:53 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $7.31 Strike: $2.54 | $73,100.00 |
DisclosureSEC source: 0001593968-21-000408 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock and Series B Preferred · 10,000 shares Expires 2026-05-21 F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan. F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
| February 10, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $7.31 | $73,100.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 11 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 20:30 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $7.25 Strike: $2.54 | $72,500.00 |
DisclosureSEC source: 0001593968-21-000383 · primary_01.xml · derivative · entry 2 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common stock and Series B Preferred · 10,000 shares Expires 2026-05-21 F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan. F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
| February 09, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $7.25 | $72,500.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 10 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 20:30 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $7.59 Strike: $2.54 | $75,900.00 |
DisclosureSEC source: 0001593968-21-000383 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock and Series B Preferred · 10,000 shares Expires 2026-05-21 F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan. F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
| February 08, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $7.59 | $75,900.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 9 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| February 05, 2021 Filed Feb 6, 2021 01:01 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $7.45 Strike: $2.54 | $74,500.00 |
DisclosureSEC source: 0001593968-21-000359 · primary_01.xml · derivative · entry 2 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common stock and Series B Preferred · 10,000 shares Expires 2026-05-21 F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan. F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
| February 05, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $7.45 | $74,500.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 8 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| February 04, 2021 Filed Feb 6, 2021 01:01 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $7.86 Strike: $2.54 | $78,600.00 |
DisclosureSEC source: 0001593968-21-000359 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common stock and Series B Preferred · 10,000 shares Expires 2026-05-21 F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan. F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
| February 04, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $7.86 | $78,600.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 7 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 19:53 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $7.53 Strike: $2.54 | $75,300.00 |
DisclosureSEC source: 0001593968-21-000345 · primary_01.xml · derivative · entry 2 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common stock and Series B Preferred · 10,000 shares Expires 2026-05-21 F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan. F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
| February 03, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $7.53 | $75,300.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 6 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 19:53 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $8.00 Strike: $2.54 | $80,000.00 |
DisclosureSEC source: 0001593968-21-000345 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common stock and Series B Preferred · 10,000 shares Expires 2026-05-21 F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan. F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
| February 02, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $8.00 | $80,000.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 5 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 00:14 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $7.91 Strike: $2.54 | $79,100.00 |
DisclosureSEC source: 0001593968-21-000297 · primary_01.xml · derivative · entry 2 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common stock and Series B Preferred · 10,000 shares Expires 2026-05-21 F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan. F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
| February 01, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $7.91 | $79,100.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 4 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 00:14 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $6.57 Strike: $2.54 | $65,700.00 |
DisclosureSEC source: 0001593968-21-000297 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common stock and Series B Preferred · 120,000 shares Expires 2026-05-21 F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan. F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
| January 29, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $6.57 | $65,700.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 3 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| January 28, 2021 Filed Jan 29, 2021 00:00 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerWarrant (right to buy) · Derivative | 10,000 | $7.53 Strike: $2.59 | $75,281.00 |
DisclosureSEC source: 0001593968-21-000251 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common stock and Series B Preferred · 0 shares Expires 2025-12-10 Read SEC document |
| January 28, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $7.53 | $75,281.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 27 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| January 27, 2021 Filed Jan 28, 2021 23:16 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $7.77 Strike: $2.59 | $77,700.00 |
DisclosureSEC source: 0001593968-21-000247 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock and Series B Preferred · 10,000 shares Expires 2025-12-10 F1 · price: The 10,000 shares were exercised from warrant grant 12/10/2015 and sold through executing the 10b5-1 plan. Read SEC document |
| January 27, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $7.77 | $77,700.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 26 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 16:21 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $9.06 Strike: $4.35 | $90,609.00 |
DisclosureSEC source: 0001593968-21-000225 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock and Series B Preferred · 10,000 shares Expires 2022-05-21 F1 · price: The 10,000 shares were exercised from grant 5/21/2015 and sold through executing the 10b5-1 plan. F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. F3 · derivative.underlying_shares: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 20,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $4.35 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. F3 · balance_after: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 20,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $4.35 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. Read SEC document |
| January 26, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $9.61 | $96,090.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 11:02 UTC | AEMETIS, INC AMTX · Entity 6595 | Disposition to issuerOption (right to buy) · Derivative | 10,000 | $7.11 Strike: $4.35 | $71,135.00 |
DisclosureSEC source: 0001593968-21-000182 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common stock and Series B Preferred · Not disclosed shares Expires 2022-05-21 F1 · price: The 10,000 shares were exercised from grant 5/21/2015 and sold through executing the 10b5-1 plan. F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. F3 · derivative.underlying_shares: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 20,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $4.35 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. F3 · balance_after: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 20,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $4.35 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. Read SEC document |
| January 25, 2021 Filed Oct 30, 2021 00:16 UTC | AEMETIS, INC AMTX · Entity 6595 | SaleCommon Stock | 10,000 | $7.11 | $71,135.00 |
DisclosureSEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 2 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,401 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan. F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 22:30 UTC | AEMETIS, INC AMTX · Entity 6595 | GrantOption (right to buy) · Derivative | 150,000 | $0.00 Strike: $3.09 | $0.00 |
DisclosureSEC source: 0001593968-21-000105 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common stock and Series B Preferred · 150,000 shares Expires 2031-01-07 F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. F2 · derivative.underlying_shares: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 150,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $3.09 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. F2 · balance_after: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 150,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $3.09 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. Read SEC document |
| March 28, 2020 Filed Mar 31, 2020 21:43 UTC | AEMETIS, INC AMTX · Entity 6595 | GrantOption (right to buy) · Derivative | 150,000 | $0.60 Strike: $0.60 | $90,000.00 |
DisclosureSEC source: 0001593968-20-000913 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common stock and Series B Preferred · 150,000 shares Expires 2030-03-28 F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. F2 · derivative.underlying_shares: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 150,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.60 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. F2 · balance_after: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 150,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.60 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. Read SEC document |
| January 09, 2020 Filed Jan 14, 2020 00:20 UTC | AEMETIS, INC AMTX · Entity 6595 | GrantOption (right to buy) · Derivative | 120,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001593968-20-000144 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common stock and Series B Preferred · 120,000 shares Expires 2030-01-09 F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. F2 · derivative.underlying_shares: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 120,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.86 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. F2 · balance_after: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 120,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.86 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:07 UTC | AEMETIS, INC AMTX · Entity 6595 | GrantOption (right to buy) · Derivative | 65,000 | $0.00 Strike: $0.92 | $0.00 |
DisclosureSEC source: 0001593968-19-001369 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common stock and Series B Preferred · 65,000 shares Expires 2029-06-05 F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. F2 · derivative.underlying_shares: Grant of Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 65,000 shares of the Company's Common Stock ("Option Shares") at and Exercise Price of $0.92 per share, and subject to the terms of the Stock Option Agreement between Reporting Person and the Company. F2 · balance_after: Grant of Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 65,000 shares of the Company's Common Stock ("Option Shares") at and Exercise Price of $0.92 per share, and subject to the terms of the Stock Option Agreement between Reporting Person and the Company. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 18:52 UTC | AEMETIS, INC AMTX · Entity 6595 | GrantOption (right to buy) · Derivative | 120,000 | $0.70 Strike: $0.70 | $84,000.00 |
DisclosureSEC source: 0001593968-19-000141 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common stock and Series B Preferred · 120,000 shares Expires 2029-01-07 F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. F2 · derivative.underlying_shares: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 120,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.70 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. F2 · balance_after: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 120,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.70 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. Read SEC document |
| May 17, 2018 Filed May 18, 2018 21:01 UTC | AEMETIS, INC AMTX · Entity 6595 | GrantOption (right to buy) · Derivative | 60,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001593968-18-000796 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common stock and Series B Preferred · 60,000 shares Expires 2023-05-17 F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. F2 · derivative.underlying_shares: Grant of Qualified Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 60,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $1.71 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. F2 · balance_after: Grant of Qualified Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 60,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $1.71 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. Read SEC document |
| January 18, 2018 Filed Jan 22, 2018 18:17 UTC | AEMETIS, INC AMTX · Entity 6595 | GrantOption (right to buy) · Derivative | 120,000 | $0.70 Strike: $0.70 | $84,000.00 |
DisclosureSEC source: 0001593968-18-000167 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common stock and Series B Preferred · 120,000 shares Expires 2028-01-18 F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. F2 · derivative.underlying_shares: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 120,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.70 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. F2 · balance_after: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 120,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.70 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 22:17 UTC | AEMETIS, INC AMTX · Entity 6595 | GrantOption (right to buy) · Derivative | 30,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0001593968-17-001257 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock and Series B Preferred · 30,000 shares Expires 2027-11-16 F1 · derivative.exercise_price: Stock Options granted with immediate vesting Read SEC document |
| January 19, 2017 Filed Jan 21, 2017 00:57 UTC | AEMETIS, INC AMTX · Entity 6595 | GrantOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001593968-17-000127 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common stock and Series B Preferred · 100,000 shares Expires 2027-01-19 F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.